Jean Jacques Bienaime bought $10K of KROS stock

Jean Jacques Bienaime, Dir of Keros Therapeutics, Inc. (KROS), bought 1,000 shares of KROS stock worth $10K, per an SEC Form 4 filed Jun 17, 2026.

It was an open-market purchase.

The trade happened on Jun 15, 2026, 2 days before it was made public.

KROS has moved -1.6% since the trade date, from $10.24 to $10.08 (Nov 12, 2026 close).